Valneva SE (VALN) Consolidated Net Income (2021 - 2026)

Valneva SE's (VALN) quarterly Consolidated Net Income came in at -$35.6 million in Q1 2026, down 438.88% year-on-year from $10.5 million in Q1 2025, and up 38.9% quarter-over-quarter from -$58.3 million in Q4 2025.

Valneva SE (VALN) Consolidated Net Income (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Consolidated Net Income across 6 years of filings, most recently posting -$35.6 million for Q1 2026.

  • Consolidated Net Income for Q1 2026 came in at -$35.6 million, down 438.88% year-over-year; the trailing twelve-month figure through Mar 2026 was -$162.3 million (down 95.09% YoY), and the FY2025 annual result was -$134.1 million, down 921.57% from the prior year.
  • Consolidated Net Income came in at -$35.6 million for Q1 2026 at Valneva SE, up from -$58.3 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $72.8 million in Q3 2022 to a low of -$151.4 million in Q2 2022.
  • The 5-year median for Consolidated Net Income is -$28.1 million (2022), against an average of -$26.3 million.
  • Across the five-year window, Consolidated Net Income surged 424.72% in 2024 and tumbled 460.17% in 2025, its largest moves.
  • Valneva SE's Consolidated Net Income stood at -$49.5 million in 2022, then surged by 34.91% to -$32.2 million in 2023, then fell by 22.85% to -$39.6 million in 2024, then tumbled by 47.25% to -$58.3 million in 2025, then jumped by 38.9% to -$35.6 million in 2026.
  • The last three Consolidated Net Income figures came in at -$35.6 million (Q1 2026), -$58.3 million (Q4 2025), and -$54.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -26.94 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -2.97 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 30.80 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -14.46 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -3.40 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 1.03 Bn
9 Abivax 94.26 Bn 94.26 Bn - -56.48 Mn
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn -35.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -35.62 Mn
Dec 31, 2025 -58.29 Mn
Sep 30, 2025 -54.74 Mn
Jun 30, 2025 -13.62 Mn
Mar 31, 2025 -6.61 Mn
Dec 31, 2024 -39.59 Mn
Sep 30, 2024 -9.77 Mn
Jun 30, 2024 -27.21 Mn
Mar 31, 2024 64.01 Mn
Dec 31, 2023 -32.23 Mn
Sep 30, 2023 -31.43 Mn
Jun 30, 2023 -26.39 Mn
Mar 31, 2023 -19.71 Mn
Dec 31, 2022 -49.51 Mn
Sep 30, 2022 72.80 Mn
Jun 30, 2022 -151.43 Mn
Mar 31, 2022 -28.10 Mn
Dec 31, 2021 193.58 Mn
Sep 30, 2021 -185.83 Mn
Jun 30, 2021 -68.19 Mn